Literature DB >> 18164056

Small-diameter biodegradable scaffolds for functional vascular tissue engineering in the mouse model.

Jason D Roh1, Gregory N Nelson, Matthew P Brennan, Tamar L Mirensky, Tai Yi, Tyrone F Hazlett, George Tellides, Albert J Sinusas, Jordan S Pober, W M Saltzman, Themis R Kyriakides, Christopher K Breuer.   

Abstract

The development of neotissue in tissue engineered vascular grafts remains poorly understood. Advances in mouse genetic models have been highly informative in the study of vascular biology, but have been inaccessible to vascular tissue engineers due to technical limitations on the use of mouse recipients. To this end, we have developed a method for constructing sub-1mm internal diameter (ID) biodegradable scaffolds utilizing a dual cylinder chamber molding system and a hybrid polyester sealant scaled for use in a mouse model. Scaffolds constructed from either polyglycolic acid or poly-l-lactic acid nonwoven felts demonstrated sufficient porosity, biomechanical profile, and biocompatibility to function as vascular grafts. The scaffolds implanted as either inferior vena cava or aortic interposition grafts in SCID/bg mice demonstrated excellent patency without evidence of thromboembolic complications or aneurysm formation. A foreign body immune response was observed with marked macrophage infiltration and giant cell formation by post-operative week 3. Organized vascular neotissue, consisting of endothelialization, medial generation, and collagen deposition, was evident within the internal lumen of the scaffolds by post-operative week 6. These results present the ability to create sub-1mm ID biodegradable tubular scaffolds that are functional as vascular grafts, and provide an experimental approach for the study of vascular tissue engineering using mouse models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164056      PMCID: PMC2375856          DOI: 10.1016/j.biomaterials.2007.11.041

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  26 in total

1.  Novel vascular graft grown within recipient's own peritoneal cavity.

Authors:  J H Campbell; J L Efendy; G R Campbell
Journal:  Circ Res       Date:  1999 Dec 3-17       Impact factor: 17.367

Review 2.  Role of mechanics in vascular tissue engineering.

Authors:  Robert M Nerem
Journal:  Biorheology       Date:  2003       Impact factor: 1.875

Review 3.  The use of animal models in developing the discipline of cardiovascular tissue engineering: a review.

Authors:  S Tawqeer Rashid; Henryk J Salacinski; George Hamilton; Alexander M Seifalian
Journal:  Biomaterials       Date:  2004-04       Impact factor: 12.479

4.  Successful application of tissue engineered vascular autografts: clinical experience.

Authors:  Goki Matsumura; Narutoshi Hibino; Yoshito Ikada; Hiromi Kurosawa; Toshiharu Shin'oka
Journal:  Biomaterials       Date:  2003-06       Impact factor: 12.479

5.  Mechanical behavior of vessel wall: a comparative study of aorta, vena cava, and carotid artery.

Authors:  Frederick H Silver; Patrick B Snowhill; David J Foran
Journal:  Ann Biomed Eng       Date:  2003 Jul-Aug       Impact factor: 3.934

Review 6.  Mouse models of atherosclerosis.

Authors:  Alan Daugherty
Journal:  Am J Med Sci       Date:  2002-01       Impact factor: 2.378

7.  Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model.

Authors:  M Watanabe; T Shin'oka; S Tohyama; N Hibino; T Konuma; G Matsumura; Y Kosaka; T Ishida; Y Imai; M Yamakawa; Y Ikada; S Morita
Journal:  Tissue Eng       Date:  2001-08

8.  Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo.

Authors:  S Kaushal; G E Amiel; K J Guleserian; O M Shapira; T Perry; F W Sutherland; E Rabkin; A M Moran; F J Schoen; A Atala; S Soker; J Bischoff; J E Mayer
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

Review 9.  Principles of genetic murine models for cardiac disease.

Authors:  Katherine E Yutzey; Jeffrey Robbins
Journal:  Circulation       Date:  2007-02-13       Impact factor: 29.690

Review 10.  Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse.

Authors:  Jordan S Pober; Alfred L M Bothwell; Marc I Lorber; Jennifer M McNiff; Jeffrey S Schechner; George Tellides
Journal:  Springer Semin Immunopathol       Date:  2003-09
View more
  66 in total

1.  Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers.

Authors:  Yaohua Gao; Tai Yi; Toshiharu Shinoka; Yong Ung Lee; Darrell H Reneker; Christopher K Breuer; Matthew L Becker
Journal:  Adv Healthc Mater       Date:  2016-07-08       Impact factor: 9.933

Review 2.  Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.

Authors:  Joseph T Patterson; Thomas Gilliland; Mark W Maxfield; Spencer Church; Yuji Naito; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

Review 3.  Cell-seeding techniques in vascular tissue engineering.

Authors:  Gustavo A Villalona; Brooks Udelsman; Daniel R Duncan; Edward McGillicuddy; Rajendra F Sawh-Martinez; Narutoshi Hibino; Christopher Painter; Tamar Mirensky; Benjamin Erickson; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part B Rev       Date:  2010-06       Impact factor: 6.389

4.  Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model.

Authors:  Mitchel R Stacy; Yuji Naito; Mark W Maxfield; Hirotsugu Kurobe; Shuhei Tara; Chung Chan; Kevin A Rocco; Toshiharu Shinoka; Albert J Sinusas; Christopher K Breuer
Journal:  J Thorac Cardiovasc Surg       Date:  2014-05-21       Impact factor: 5.209

5.  TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.

Authors:  Yong-Ung Lee; Juan de Dios Ruiz-Rosado; Nathan Mahler; Cameron A Best; Shuhei Tara; Tai Yi; Toshihiro Shoji; Tadahisa Sugiura; Avione Y Lee; Frank Robledo-Avila; Narutoshi Hibino; Jordan S Pober; Toshiharu Shinoka; Santiago Partida-Sanchez; Christopher K Breuer
Journal:  FASEB J       Date:  2016-04-08       Impact factor: 5.191

6.  Development of an operator-independent method for seeding tissue-engineered vascular grafts.

Authors:  Brooks Udelsman; Narutoshi Hibino; Gustavo A Villalona; Edward McGillicuddy; Alejandro Nieponice; Yuki Sakamoto; Shojiro Matsuda; David A Vorp; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2011-05-06       Impact factor: 3.056

7.  Novel application and serial evaluation of tissue-engineered portal vein grafts in a murine model.

Authors:  Mark W Maxfield; Mitchel R Stacy; Hirotsugu Kurobe; Shuhei Tara; Tai Yi; Muriel A Cleary; Zhen W Zhuang; Manuel I Rodriguez-Davalos; Sukru H Emre; Yasuko Iwakiri; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2017-12-07       Impact factor: 3.806

8.  Computational model of the in vivo development of a tissue engineered vein from an implanted polymeric construct.

Authors:  K S Miller; Y U Lee; Y Naito; C K Breuer; J D Humphrey
Journal:  J Biomech       Date:  2013-10-21       Impact factor: 2.712

9.  Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.

Authors:  Juan de Dios Ruiz-Rosado; Yong-Ung Lee; Nathan Mahler; Tai Yi; Frank Robledo-Avila; Diana Martinez-Saucedo; Avione Y Lee; Toshihiro Shoji; Eric Heuer; Andrew R Yates; Jordan S Pober; Toshiharu Shinoka; Santiago Partida-Sanchez; Christopher K Breuer
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

10.  A small diameter, fibrous vascular conduit generated from a poly(ester urethane)urea and phospholipid polymer blend.

Authors:  Yi Hong; Sang-Ho Ye; Alejandro Nieponice; Lorenzo Soletti; David A Vorp; William R Wagner
Journal:  Biomaterials       Date:  2009-02-01       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.